Cite

HARVARD Citation

    Leal, T. et al. (2022). A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782). Cancer medicine. pp. 3969-3981. [Online]. 
  
Back to record